SCHEMBL8895024

SCHEMBL8895024

CN1CS/C(=C\c2ccc(O)c(C(C)(C)C)c2)C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.43
PTGS1 P23219 4/20 0.43
SLC2A1 P11166 2/20 0.43
HSD17B3 P37058 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ATM Q13315 1/20 0.39
S1PR1 P21453 5/20 0.38
S1PR3 Q99500 2/20 0.38
CYP2C9 P11712 2/20 0.37
NR1I2 O75469 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
MIF P14174 1/20 0.37
TYR P14679 1/20 0.37
ALOX15 P16050 1/20 0.37
HTT P42858 1/20 0.37
NFE2L2 Q16236 1/20 0.37
HSD17B10 Q99714 1/20 0.37
RARA P10276 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8894274 1.00 PTGS2 (0.43) PTGS2PTGS1SLC2A1HSD17B3MEN1
SCHEMBL8532780 0.85 PTGS2 (0.56) PTGS2PTGS1MEN1KMT2ACYP2C9
SCHEMBL8532777 0.85 PTGS2 (0.56) PTGS2PTGS1MEN1KMT2ACYP2C9
SCHEMBL8893231 0.81 PTGS2 (0.48) PTGS2PTGS1MEN1KMT2ACYP2C9
SCHEMBL8991978 0.81 PTGS2 (0.48) PTGS2PTGS1MEN1KMT2ACYP2C9
SCHEMBL8957291 0.78 PTGS2 (0.45) PTGS2PTGS1MEN1KMT2ACYP2C9
SCHEMBL8957294 0.78 PTGS2 (0.45) PTGS2PTGS1MEN1KMT2ACYP2C9
SCHEMBL8895054 0.76 PTGS2 (0.44) PTGS2PTGS1MEN1KMT2ACYP2C9
SCHEMBL8933407 0.76 PTGS2 (0.44) PTGS2PTGS1MEN1KMT2ACYP2C9
SCHEMBL8710470 0.76 HSD17B3 (0.70) HSD17B3MEN1KMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5691367-A ANTIINFLAMMATORY AGENTS OR ANTIARTHRITIC AGENTS ELI LILLY AND COMPANY (US) 1997-11-25 US disclosed
WO-1996022772-A1 METHOD FOR TREATING MULTIPLE SCLEROSIS ELI LILLY AND COMPANY (US) 1996-08-01 WO disclosed
EP-0722729-A2 Aryl-substituted rhodanines for treating multiple sclerosis ELI LILLY AND COMPANY (US) 1996-07-24 EP disclosed
EP-0391644-B1 Aryl-substituted rhodanine derivatives LILLY CO ELI (US) 1996-06-19 EP disclosed
US-5356917-A Antiischemic, antiinflammatory, antiarthritic agents, treat-ment of dystrophic mammals ELI LILLY AND COMPANY (US) 1994-10-18 US disclosed
US-5158966-A Aryl-substituted rhodanine derivatives THE UNIVERSITY OF COLORADO FOUNDATION, INC. (US) 1992-10-27 US disclosed
EP-0500337-A1 Composition containing aryl-substituted rhodanine derivatives for the treatment of type I diabetes UNIVERSITY OF COLORADO FOUNDATION, INC. (US) 1992-08-26 EP disclosed
EP-0391644-A2 Aryl-substituted rhodanine derivatives ELI LILLY AND COMPANY (US) 1990-10-10 EP disclosed